Actively Recruiting
Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
Led by Imperial College London · Updated on 2022-08-08
150
Participants Needed
1
Research Sites
330 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to investigate the continued usage of standard diabetes medications in the post operative period following bariatric surgery to determine whether this approach may improve long term diabetes control. At present, the standard of treatment in patients with type 2 diabetes is that all medication is stopped in the immediate postoperative period and only re-started if symptoms of diabetes re-emerge. Although a large proportion of patients with diabetes will initially go in to remission, 80% experience relapse within five years. This study is needed to determine whether continuing medications is not only safe but will improve long term outcomes for patients with diabetes.
CONDITIONS
Official Title
Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Eligible for bariatric surgery according to NICE guidelines (GC 189)
- Diagnosed with type 2 diabetes mellitus
- Body Mass Index (BMI) greater than 30 kg/m2
You will not qualify if you...
- Hospitalized within the past 30 days
- Having recurrent episodes of low blood sugar (hypoglycemia)
- Having recurrent episodes of low blood pressure (hypotension)
- Contraindications to bariatric surgery
- Previous bariatric surgery
- Currently pregnant
- Breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University College Dublin
Dublin, Ireland
Actively Recruiting
Research Team
A
Alexander Miras, MRCP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here